Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

New Nanobody-Based Anti-Venom Promises Breakthrough in Treating Snakebites

Healthcare/Biotech

|

Updated on 31 Oct 2025, 06:50 am

Whalesbook Logo

Reviewed By

Aditi Singh | Whalesbook News Team

Short Description :

International researchers have developed a revolutionary anti-venom for snakebites, a neglected tropical disease causing millions of deaths annually. Unlike traditional methods using large antibodies, this new approach utilizes antibody fragments called 'nanobodies.' This technology offers significant advantages, including broader effectiveness against multiple snake species, faster tissue penetration, reduced risk of severe side effects, and better neutralization of venom toxins. The new anti-venom has shown promising results in neutralizing venom from 17 out of 18 tested African snake species. Clinical trials are anticipated within one to two years.
New Nanobody-Based Anti-Venom Promises Breakthrough in Treating Snakebites

▶

Detailed Coverage :

An international research team, led by Andreas Hougaard Laustsen-Kiel from DTU Bioengineering in Denmark, has developed a potential game-changer for snakebite envenoming, a neglected tropical disease causing significant global mortality and morbidity. This new anti-venom utilizes antibody fragments called 'nanobodies,' offering advantages over traditional methods which use larger antibodies from animals like horses. Nanobodies are smaller, penetrate tissues faster and deeper, and carry a lower risk of severe immune reactions. A major limitation of current anti-venoms is their specificity to only a few snake species. The new research combines eight nanobodies into a cocktail effective against venom from 18 medically relevant African snake species. Preclinical tests showed it neutralized venom from 17 out of 18 species.

Impact: This breakthrough could significantly reduce snakebite-related deaths, disabilities, and amputations worldwide, particularly in affected tropical regions. It offers hope for more effective and safer treatment options. Rating: 9/10

Difficult Terms: * Nanobodies: Antibody fragments, much smaller than conventional antibodies, used in the new anti-venom for better tissue penetration and reduced side effects. * Snakebite Envenoming: A disease caused by the injection of venom from a venomous snake. * Neglected Tropical Disease (NTD): Infectious diseases affecting poor populations in tropical/subtropical regions. * Antibodies: Proteins produced by the immune system to fight infections. * Neurotoxins: Poisons that attack the nervous system, causing paralysis. * Cytotoxins: Poisons that damage cells and tissues. * In vivo testing: Experiments conducted within a living organism.

More from Healthcare/Biotech


Latest News

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Auto

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Stocks to buy: Raja Venkatraman's top picks for 4 November

Brokerage Reports

Stocks to buy: Raja Venkatraman's top picks for 4 November

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Mutual Funds

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

Tech

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

Banking/Finance

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)

Industrial Goods/Services

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)


Renewables Sector

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030

Renewables

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030


Energy Sector

India's green power pipeline had become clogged. A mega clean-up is on cards.

Energy

India's green power pipeline had become clogged. A mega clean-up is on cards.

More from Healthcare/Biotech


Latest News

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Stocks to buy: Raja Venkatraman's top picks for 4 November

Stocks to buy: Raja Venkatraman's top picks for 4 November

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)


Renewables Sector

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030


Energy Sector

India's green power pipeline had become clogged. A mega clean-up is on cards.

India's green power pipeline had become clogged. A mega clean-up is on cards.